Le contenu de cette page nécessite une version plus récente d’Adobe Flash Player.

Obtenir le lecteur Adobe Flash


translationalFluorescence imaging is a non-radioactive technique which requires the injection of fluorescent moiety such as ICG and a totally safe illumination of the patient by visible and near-infrared light.


For angiographic imaging fluorescence can in some indications such as the control of anastomosis advantageously be used in place of Xray imaging which requires also the injection of an iodinated contrast agent.


For lymphatic drainage imaging and lymph node detection fluorescence can sometime advantageously be used in place of gamma imaging which requires the injection of Tc99M a radioactive product.


diagnosisFluoptics® provides molecular probes specifically targeting integrins over-expressed in angiogenesis and in many cancerous tumors.


The visualization of the area concentrating theses probes during surgery provides a in vivo biological information that will help the surgeon to characterize cancerous areas, to define tumor margins and to protect normal vital structures.


diagnosisThe filtering of Fluobeam® and Fluostick™ does not require to perform the imaging in the dark.


Most of the time the imaging can be performed with the OR neons ON.
Fluobeam® and Fluostick™ provide a complementary white light illumination with a very high color rendering index to illuminate the surgical field.


diagnosis Fluoptics® solutions (Angiostamp™ fluorescent probes and imaging devices) are used on small and large animals at the preclinical stage in cancer research.

This research allowed to bring Fluobeam® and Fluostick™ on the clinical market as CE medical device of class IIa. Fluoptics® is working at the translation to human of the Angiostamp™ fluorescent probe in order to perform intra operative tumor


diagnosisFluobeam® and Fluostick™ imaginig devices are providing real time imaging of the fluorescence in the field of operation.

The specific filtering and excitation technology of these devices pushes the detection limit to levels compatible with multiple ICG injection in the same procedure.

This high sensitivity makes the Fluobeam® and Fluostick™ compatible with a fine tumor margin delineation when working with molecular imaging probes.


diagnosisThe Fluobeam® allows visualizing variable size of field of view with a high resolution that is only limited by the number of pixels of the camera. At the lowest resolution Fluobeam® allows to clearly visualize fluorescent structures as small as 300µm in diameter. At the highest resolution the system allows to visualize structures as small as 60µm in diameter


puce Improve patient care

puce Allow for less invasive procedures

puce Improve the safety of surgical procedures

puce Cover a large range of surgical indications

puce Provide a simple, easy to use platform

puce Decrease the time required for a surgical

puce Intervention Reduce costs for the hospital

Medical device
Fluobeam® and Fluostick™ Class IIa
Fluocart™ Class I
This medical device can be used only by healthcare professionals.
Before first use, user must read the medical device instructions for use and its label.

BHT – Bât. 52
7, parvis Louis Néel, CS 20050
38040 Grenoble Cedex 9, France
Tel: +33 438 782 878